KannaLife Sciences
Biotechnology company developing cannabinoid-based drug candidates targeting chronic traumatic encephalopathy, hepatic encephalopathy, and other neurological conditions.
About
What KannaLife Sciences is
Biotechnology company developing cannabinoid-based drug candidates targeting chronic traumatic encephalopathy, hepatic encephalopathy, and other neurological conditions.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://kannalife.com |
| Status coverage | Public status page |
| Founded | 2014 |
| Headquarters | New York, New York, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...